ROCKET PHARMACEUTICALS, INC. (RCKT) › Shareholders' EquityROCKET PHARMACEUTICALS, INC. (RCKT) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$38.90M2014: -$51.56M2015: $15.54M2016: $8.37M2017: $15.52M2018: $194.04M2019: $307.30M2020: $503.52M2021: $454.72M2022: $489.69M2023: $492.57M2024: $463.23M2025: $277.22M$277.22M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$277.22M-40.2%2024$463.23M-6.0%2023$492.57M+0.6%2022$489.69M+7.7%2021$454.72M-9.7%2020$503.52M+63.9%2019$307.30M+58.4%2018$194.04M+1150.3%2017$15.52M+85.4%2016$8.37M-46.1%2015$15.54M+130.1%2014-$51.56M-32.6%2013-$38.90M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share